FDAsafety guidance84% confidence
Compounding Risk Alerts
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Medline; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
FDA issues compounding risk alerts to communicate information to alert health care professionals to adverse events and outbreaks related to compounded drugs so that practitioners can more effectively protect patients from unsafe, ineffective, and poor quality compounded medicines.
Supporting Context
- Therapeutic area
- Infection Control · Medical Devices
- Sub-indication
- General
Related signal: FDA Alerts on Non-Sterile BD ChloraPrep Applicators in Medline Convenience Kits